Medical microbiology is responsible for the detection of bacteria, viruses, fungi, and parasites in patient samples. Depending on the location of the infection, blood, stool, urine, respiratory secretions, or samples taken during an operation, are the starting point for diagnostics using microscopic, cultural, serological, and molecular methods. With the latest microbiological methods and the latest laboratory technology, we can detect a wide range of pathogens in samples.

Fast and accurate diagnosis is key in critical care settings and for immuno-compromised patients. Eurofins’ Target Enriched Multiplex PCR (TEM-PCRTM) proprietary technology improves patient outcomes thanks to fast turnaround, higher sensitivity and higher specificity. The method offers simplicity due to single-sample collection and identifies difficult to culture pathogens. Different specimens can be analysed with this technology and no bacterial isolation is required.

Eurofins clinical diagnostics laboratories are able to identify viral and bacterial pathogens from a single specimen using our TEM-PCRTM technology. Co-detection allows physicians to administer appropriate treatment, i.e. antibiotic or antiviral therapy. This evidence-based approach translates into improved quality and cost effectiveness in terms of patient care.

Genotypic testing allows for the identification of individual antibiotic resistance and response. Detection of a gene resistant target can provide useful information to guide the appropriate course of action to successfully treat an infection. Genotypic characterisation of antimicrobial resistance (AMR) is based on seventeen genes associated with resistance to beta-lactams, quinolones and macrolides. Depending on the results, an optimal therapy for the patient will be recommended.

How antiviral drugs and antibiotics are metabolised by an individual patient can also be investigated by Eurofins clinical diagnostics laboratories through pharmacogenetics testing. Based on the results of these tests, physicians can stratify patients and administer the correct dosage depending on the patient’s drug metabolism profile.